跳至主要内容
临床试验/NL-OMON36456
NL-OMON36456已完成不适用

An open-label, two-period, fixed sequence study to evaluate the effects of multiple oral doses of AFQ056 on the pharmacokinetics of a monophasic oral contraceptive in healthy female volunteers - CAFQ056A2133

ovartis0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
ovartis
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy female subjects, 18 to 40 years of age, BMI 18 - 30 kg/m2, OC containing EES (30µg)/LVG (150µg) for a least of three cycles prior to screening.

排除标准

  • Subjects that are pregnant, post-menopausal, breast-feeding or have stopped- breastfeeding less than 6 months before screening, smoker, clinically significant abnormalities during screening and baseline

研究者

发起方
ovartis

相似试验

已完成
不适用
Open-label, 2-period, fixed sequence study to assess the bioavailability of aluminium, formulated as aluminium chlorohydrate, after topical application of a representative antiperspirant formulation in healthy women using a [26Al] microtracer approachGeneral health
NL-OMON46500Cosmetics Europe  The Personal Care Association A.I.S.B.L.12
进行中(未招募)
不适用
Two-period, single-dose pharmacokinetic study in male adolescent patients with Fragile X Syndrome (FXS).Fragile X SyndromeMedDRA version: 14.0Level: PTClassification code 10017324Term: Fragile X syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2010-019353-18-Outside-EU/EEAovartis Pharma Services AG12
已完成
1 期
A DDI Study to Evaluate the Effects of Itraconazole and Fluoxetine on AK0529 in Healthy VolunteersRespiratory Syncytial Virus Infection
ACTRN12619001413112Ark Biosciences Pty Ltd28
已完成
不适用
One-sequence, two-period, open-label study to evaluate the effects of FTY720 on the pharmacokinetics of an oral contraceptive (levonorgestrel/ethinyl estradiol) in healthy female volunteers.multiple sclerose10012303MS
NL-OMON35177ovartis31
已完成
1 期
An Open-label, Single-arm, Two-period, Fixed Sequential-dose Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of SP 102 (Dexamethasone Sodium Phosphate Injectable Gel) Administered by Epidural Injection Compared with Dexamethasone Sodium Phosphate Injection, Administered by Intravenous Injection in Subjects with Lumbosacral RadiculopathyPainAnaesthesiology - Pain management
ACTRN12619000448145Semnur Pharmceuticals16